Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: An international multicenter cohort study

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Krinsley, James S ^a   Egi, Moritoki ^b   Kiss, Alex ^c   Devendra, Amin N ^d   Schuetz, Philipp ^e   Maurer, Paula M ^f   Schultz, Marcus J ^g   van Hooijdonk, Roosmarijn T M ^g   Kiyoshi, Morita ^b   Mackenzie, Iain M J ^h   Annane, Djillali ⁱ   Stow, Peter ^j   Nasraway, Stanley A ^k   Holewinski, Sharon ^k   Holzinger, Ulrike ^l   Preiser, Jean Charles ^m   Vincent, Jean Louis ^m   Bellomo, Rinaldo ⁿ  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

^d Morton Plant Hospital   (United States)

^e Kantonsspital Aarau   (Switzerland)

^f BayCare Health System   (United States)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j GEELONG HOSPITAL   (Australia)

^k TUFTS MEDICAL CENTER   (United States)

^l MEDICAL UNIVERSITY OF VIENNA   (Austria)

^m ERASME HOSPITAL   (Belgium)

ⁿ AUSTIN HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; INTERNATIONAL COOPERATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COHORT STUDIES; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; GLYCEMIC INDEX; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84874398872     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12547     Document Type: Article

References (59)

1. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009, 373:1798-1807. 10.1016/S0140-6736(09)60553-5, 3144755, 19465235.
2. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78:1471-1478. 10.4065/78.12.1471, 14661676.
3. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009, 37:3001-3009. 10.1097/CCM.0b013e3181b083f7, 2905804, 19661802.
4. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
5. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004, 79:992-1000. 10.4065/79.8.992, 15301325.
6. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 10.1056/NEJMoa052521, 16452557.
7. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hargog C, Natanson C, Loeffler M, Reihart K for the German Competence Network Sepsis Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958, Reihart K for the German Competence Network Sepsis.
8. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35:1738-1748. 10.1007/s00134-009-1585-2, 19636533.
9. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Salim K, Riette B, Maram S. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008, 36:3190-3197. 10.1097/CCM.0b013e31818f21aa, 18936702.
10. The NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. The NICE-SUGAR Study Investigators.
11. The NICE-SUGAR Study Investigators Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367:1108-1118. The NICE-SUGAR Study Investigators.
12. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, Schultz MJ, Rosendaal FR, Hoekstra JB. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006, 34:2714-2718. 10.1097/01.CCM.0000241155.36689.91, 16943734.
13. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35:2262-2267. 10.1097/01.CCM.0000282073.98414.4B, 17717490.
14. Bagshaw SM, Egi M, George C, Bellomo R. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009, 37:463-470. 10.1097/CCM.0b013e318194b097, 19114915.
15. Hermanides J, Bosman RJ, Vriesendorp TM, Dotsch R, Rosendaal FR, Zandstra DF, Hoekstra JB, DeVries JH. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010, 38:1430-1434. 10.1097/CCM.0b013e3181de562c, 20386307.
16. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010, 85:217-224. 10.4065/mcp.2009.0394, 2843109, 20176928.
17. Krinsley JS, Schultz MJ, Spronk PE, Harmsen RE, van Braam Houckgeest F, van der Sluijs JP, Melot C, Preiser JC. Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care 2011, 15:R173. 10.1186/cc10322, 3387616, 21787410.
18. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105:244-252. 10.1097/00000542-200608000-00006, 16871057.
19. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008, 36:3008-3013. 10.1097/CCM.0b013e31818b38d2, 18824908.
20. Ali NA, O'Brien JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008, 36:2316-2321. 10.1097/CCM.0b013e3181810378, 3176449, 18596625.
21. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008, 74:679-685.
22. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009, 13:R91. 10.1186/cc7921, 2717463, 19534781.
23. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010, 38:838-842. 10.1097/CCM.0b013e3181cc4be9, 20035218.
24. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol 2009, 3:1292-1301. 2787029, 20144383.
25. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010, 38:1021-1029. 10.1097/CCM.0b013e3181cf710e, 20124887.
26. Mackenzie IM, Whitehouse T, Nightingale PG. The metrics of glycaemic control in critical care. Intensive Care Med 2011, 37:435-443. 10.1007/s00134-010-2103-2, 21210080.
27. Krinsley JS. Understanding glycemic control in the critically ill: 3 domains are better than one. Intensive Care Med 2011, 37:382-384. 10.1007/s00134-010-2110-3, 21210079.
28. Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the 3 domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care 2012, 15:151-160. 10.1097/MCO.0b013e32834f0009, 22234163.
29. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005, 80:1558-1567. 10.4065/80.12.1558, 16342648.
30. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg 2006, 18:317-325. 10.1053/j.semtcvs.2006.12.003, 17395028.
31. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008, 36:2249-2255. 10.1097/CCM.0b013e318181039a, 18664780.
32. Graham BB, Keniston A, Gajic O, Trillo Alvarez CA, Medvedev S, Douglas IS. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med 2010, 38:16-24. 10.1097/CCM.0b013e3181b9eaa5, 19789450.
33. Vincent JL, Preiser JC, Sprung CL, Moreno R, Sakr Y. Insulin-treated diabetes is not associated with increased mortality in critically ill patients. Crit Care 2010, 14:R12. 10.1186/cc8866, 2875526, 20132545.
34. Stegenga ME, Vincent JL, Vail GM, Xie J, Haney DJ, Williams MD, Bernard GR, van der Poll T. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med 38:539-545.
35. Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 2009, 13:R18. 10.1186/cc7717, 2688136, 19216780.
36. Krinsley JS, Fiser M. The diabetes paradox: diabetes is not independently associated with increased mortality in critically ill patients. Hosp Pract 2012,
37. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
38. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest 2005, 127:1749-1751. 10.1378/chest.127.5.1749, 15888855.
39. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008, 83:400-405. 10.4065/83.4.400, 18380985.
40. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005, 33:2778-2785. 10.1097/01.CCM.0000189939.10881.60, 16352960.
41. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care 2006, 10:R135. 10.1186/cc5048, 1751062, 16981981.
42. Krinsley JS. Moving closer to untangling a sweet web: hyperglycemia, diabetic status, and mortality in the critically ill. Crit Care Med 2010, 38:295-296. 10.1097/CCM.0b013e3181bfe9e5, 20023467.
43. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011, 39:105-111. 10.1097/CCM.0b013e3181feb5ea, 20975552.
44. Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
45. ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
46. Dotson S, Freeman R, Failing HJ, Adler GK. Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care 2008, 31:1222-1223. 10.2337/dc07-2243, 18332163.
47. Schlenk F, Graetz D, Nagel A, Schmidt M, Sarrafzadeh AS. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care 2008, 12:R9. 10.1186/cc6776, 2374587, 18218076.
48. Keller-Wood ME, Shinsako J, Dallman MF. Inhibition of the adrenocorticotropin and corticosteroid responses to hypoglycemia after prior stress. Endocrinology 1983, 113:491-496. 10.1210/endo-113-2-491, 6307641.
49. Herlein JA, Morgan DA, Phillips BG, Haynes WG, Sivitz WI. Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses. Endocrinology 2006, 147:2781-2788. 10.1210/en.2005-1247, 16527844.
50. Dieguez G, Fernandez N, Garcia JL, Garcia-Villalon AL, Monge L, Gomez B. Role of nitric oxide in the effects of hypoglycemia on the cerebral circulation in awake goats. Eur J Pharmacol 1997, 330:185-193. 10.1016/S0014-2999(97)00181-7, 9253952.
51. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus: recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993, 91:819-828. 10.1172/JCI116302, 288033, 8450063.
52. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003, 52:2795-2804. 10.2337/diabetes.52.11.2795, 14578299.
53. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687. 10.1001/jama.295.14.1681, 16609090.
54. Watada H, Azuma K, Kawamori R. Glucose fluctuation on the progression of diabetic macroangiopathy: new findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract 2007, 77(Suppl 1):S58-S61.
55. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, Shimizu T, Miura K, Mine T, Tanaka Y, Mitsumata M, Watada H. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006, 26:2275-2280. 10.1161/01.ATV.0000239488.05069.03, 16888238.
56. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001, 281:E924-E930.
57. American Diabetes Association Standards of medical care in diabetes. Diabetes Care 2010, 33(Suppl 1):S11-S61. 2797382, 20042772, American Diabetes Association.
58. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011, 154:260-267.
59. Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol 2009, 3:1309-1318. 2787031, 20144385.